A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer
Condition: Triple Negative Breast Neoplasms Interventions: Drug: Atezolizumab; Drug: Placebo; Drug: Gemcitabine; Drug: Capecitabine; Drug: Carboplatin Sponsor: Hoffmann-La Roche Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials